Rapporten
Verifierade nyheter om finansiering, huvudkontor och ledarskap från världens mest innovativa företag
116 rapporter och fler
Khartis Therapeutics Raises $50M Series B for Oral Immunology Medicines
Khartis Therapeutics raised a $50 million Series B led by Forge Life Science Partners to advance its oral IGF-1R inhibitor for thyroid eye disease.
Diagonal Therapeutics Raises $125M Series B | Antibody Therapeutics
Biotech startup Diagonal Therapeutics secures $125 million Series B for rare genetic disease treatments.
AAVantgarde Raises $141 million in Series B
AAVantgarde, a Biotechnology company based in Milan Italy, has raised $141 million in Series B at a Undisclosed led by Multiple investors including Italian.
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Azafaros Raises $146M Series B to Transform Biotech
Azafaros has secured $146M Series B in funding to accelerate growth and innovation in the biotech sector. Specialty pharmaceutical company advancing nizubaglustat for Gaucher disease and Parkinson's disease...
Biogen Inc Headquarters - Office Location & Address
Discover Biogen Inc's headquarters at 225 Binney St, Cambridge, MA 02142. Biotechnology company pioneering science to deliver innovative medicines for neurodegenerative and rare diseases. Leader in multiple sclerosis treatments and Alzheimer's disease research with Aduhelm approval.. Learn about the office facilities and work environment.
Lark Health Headquarters - Office Location & Address
Discover Lark Health's headquarters at 2685 Marine Way, Mountain View, CA 94043. AI health coach for chronic disease prevention and management available 24/7 via smartphone. Chronic disease prevention platform using AI coaching for diabetes prevention, hypertension, and behavioral health.. Learn about the office facilities and work environment.
Cleerly Raises $106M Series C | AI Heart Disease Detection
Digital healthcare company Cleerly secures $106 million Series C led by Insight Partners for cardiac AI expansion.
NanoMedicine Labs Raises $460M Series C to Transform Healthcare
NanoMedicine Labs secures $460M in Series C funding at $5.8B valuation to advance phase iii clinical trials, scale manufacturing capabilities, and expand pipeline to rare diseases.
Visar 9 rapporter • Sida 1 • Kategori: all
Ligga steget före marknaden
Få veckovisa insikter levererade till din inkorg. Ingen spam, bara intelligens.